Arcus Capital Partners LLC boosted its position in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 6.9% during the fourth ...

The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective ...

Arcus Biosciences Inc. (NYSE: RCUS) shares are trading lower Tuesday after the company announced a $150 million common stock ...

Casdatifan targets a transcription factor that binds with other proteins to switch off the body’s anti-inflammatory ...

California-based Arcus Biosciences, a biopharma developing differentiated molecules and combination therapies for people with ...

Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...

Barclays analyst Peter Lawson maintained a Buy rating on Arcus Biosciences (RCUS – Research Report) today and set a price target of $29.00. The ...

Marcus Rashford has not given up on his dream of playing in Spain, despite sealing a dramatic deadline-day loan move The post ...

Marcus Rashford impressed on his Premier League debut for Aston Villa on Saturday, but has his heart set on a summer move ...